Citigroup Reaffirms BP PLC (LON:BP) As “Neutral”; Has Price Target Of GBX 510.00; Retractable Technologies (RVP) Has 1.17 Sentiment

Retractable Technologies, Inc. designs, develops, makes, and markets safety syringes and other safety medical products for the healthcare industry in the United States and internationally. The company has market cap of $24.06 million. The Company’s principal products comprise VanishPoint 0.5mL insulin syringes; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; EasyPoint needles; VanishPoint blood collection tube holders; VanishPoint IV safety catheters; small diameter tube adapters; allergy trays; Patient Safe syringes; Patient Safe Luer caps; and VanishPoint blood collection sets, as well as VanishPoint autodisable syringes. It currently has negative earnings. The firm is also developing retractable needles and syringes, glass syringes, dental syringes, IV catheter introducers, and blood collection sets.

BP PLC (LON:BP) had its stock rating noted as “Neutral” by analysts at Citigroup. Citigroup currently has a GBX 510.00 TP on the 95.32B GBP market cap company or 6.28% upside potential. This was revealed in a research note on Wednesday morning.

Wealthtrust Axiom Llc holds 0.14% of its portfolio in Retractable Technologies, Inc. for 539,303 shares. Drw Securities Llc owns 45,600 shares or 0.01% of their US portfolio. Moreover, A.R.T. Advisors Llc has 0% invested in the company for 15,383 shares. The New York-based Blackrock Inc. has invested 0% in the stock. Bridgeway Capital Management Inc, a Texas-based fund reported 34,200 shares.

The stock increased 0.07% or $0.0005 during the last trading session, reaching $0.7365. About 204,396 shares traded. Retractable Technologies, Inc. (RVP) has declined 52.59% since February 7, 2017 and is downtrending. It has underperformed by 69.29% the S&P500.

The stock increased 0.76% or GBX 3.6 during the last trading session, reaching GBX 478.6. About 8.89M shares traded. BP p.l.c. (LON:BP) has 0.00% since February 7, 2017 and is . It has underperformed by 16.70% the S&P500.